tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MCRB Stock Latest News

Seres Therapeutics announces receipt of expected $50M installment payment
The FlySeres Therapeutics announces receipt of expected $50M installment payment
6d ago
MCRB
Seres Therapeutics Strengthens Future with VOWST Sale
PremiumCompany Announcements
Seres Therapeutics Strengthens Future with VOWST Sale
9d ago
8K
MCRB
Seres announces new translational biomarker results from SER-155 Phase 1b study
PremiumThe Fly
Seres announces new translational biomarker results from SER-155 Phase 1b study
13d ago
MCRB
Xilio Therapeutics appoints Caroline Hensley as CLO
PremiumThe Fly
Xilio Therapeutics appoints Caroline Hensley as CLO
1M ago
XLO
MCRB
Seres Therapeutics to highlight plans for SER-155 at JPMorgan conference
PremiumThe Fly
Seres Therapeutics to highlight plans for SER-155 at JPMorgan conference
1M ago
MCRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
KOD
AGIO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
KOD
AGIO
Seres Therapeutics granted Breakthrough Therapy designation for SER-155
Premium
The Fly
Seres Therapeutics granted Breakthrough Therapy designation for SER-155
1M ago
MCRB
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
API
BCE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RNA
AGEN
Seres Therapeutics Reports Q3 2024 Results and Strategic Progress
PremiumCompany Announcements
Seres Therapeutics Reports Q3 2024 Results and Strategic Progress
2M ago
MCRB
Seres reports Q3 EPS from continuing operations (33c), consensus (24c)
PremiumThe Fly
Seres reports Q3 EPS from continuing operations (33c), consensus (24c)
2M ago
MCRB
Correction: Seres reports Q3 EPS from continuing operations (33c)
PremiumThe FlyCorrection: Seres reports Q3 EPS from continuing operations (33c)
2M ago
MCRB
Seres Therapeutics Faces Nasdaq Challenge Amid Trial Success
Premium
Company Announcements
Seres Therapeutics Faces Nasdaq Challenge Amid Trial Success
2M ago
8K
MCRB
Seres Therapeutics reports Q3 EPS 58c, consensus (24c)
Premium
The Fly
Seres Therapeutics reports Q3 EPS 58c, consensus (24c)
2M ago
MCRB
Seres Therapeutics expects cash to fund operations into Q4 of 2025
PremiumThe Fly
Seres Therapeutics expects cash to fund operations into Q4 of 2025
2M ago
MCRB
Seres Therapeutics Inc. (MCRB) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Seres Therapeutics Inc. (MCRB) Q3 Earnings Cheat Sheet
3M ago
MCRB
Seres Therapeutics downgraded to Underweight from Neutral at JPMorgan
PremiumThe Fly
Seres Therapeutics downgraded to Underweight from Neutral at JPMorgan
3M ago
MCRB
Seres Therapeutics rumor highlighted in Betaville blog
PremiumThe Fly
Seres Therapeutics rumor highlighted in Betaville blog
3M ago
MCRB
Seres Therapeutics files to sell 14.29M shares of common stock for holders
PremiumThe FlySeres Therapeutics files to sell 14.29M shares of common stock for holders
4M ago
MCRB
Seres Therapeutics Streamlines Focus with VOWST Sale to Nestlé
Premium
Company Announcements
Seres Therapeutics Streamlines Focus with VOWST Sale to Nestlé
4M ago
8K
MCRB
Seres shareholders request clarity from board about possible Nestle offer
Premium
The Fly
Seres shareholders request clarity from board about possible Nestle offer
4M ago
MCRB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >